Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 13.28 NOK -1.63%
Market Cap: 691.1m NOK
Have any thoughts about
Arcticzymes Technologies ASA?
Write Note

Relative Value

The Relative Value of one AZT stock under the Base Case scenario is 28.77 NOK. Compared to the current market price of 13.28 NOK, Arcticzymes Technologies ASA is Undervalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AZT Relative Value
Base Case
28.77 NOK
Undervaluation 54%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
45
Median 3Y
17.4
Median 5Y
21.9
Industry
7.7
Forward
5.9
vs History
20
vs Industry
2
Median 3Y
85.1
Median 5Y
75.2
Industry
22.7
Forward
46.1
vs History
4
vs Industry
4
Median 3Y
60.9
Median 5Y
62.4
Industry
21.6
vs History
vs Industry
0
Median 3Y
84.7
Median 5Y
73.7
Industry
25.2
vs History
98
vs Industry
23
Median 3Y
6.9
Median 5Y
12.5
Industry
2.5
vs History
92
vs Industry
41
Median 3Y
15.5
Median 5Y
21.2
Industry
7.7
Forward
4.5
vs History
92
vs Industry
41
Median 3Y
16.1
Median 5Y
19.3
Industry
9
vs History
4
vs Industry
2
Median 3Y
68.9
Median 5Y
61.9
Industry
4.2
Forward
173.2
vs History
vs Industry
1
Median 3Y
86.9
Median 5Y
69.2
Industry
4.1
Forward
34.6
vs History
6
vs Industry
4
Median 3Y
55.6
Median 5Y
57.4
Industry
5.7
vs History
vs Industry
1
Median 3Y
73.8
Median 5Y
71.8
Industry
3.6
vs History
98
vs Industry
20
Median 3Y
23
Median 5Y
31.5
Industry
4.6

Multiples Across Competitors

AZT Competitors Multiples
Arcticzymes Technologies ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Arcticzymes Technologies ASA
OSE:AZT
689.5m NOK 6.4 98.5 116.7 -352.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 797 580.3 -179 646.3 -218 147.8 -215 658.5
US
Abbvie Inc
NYSE:ABBV
320.1B USD 5.8 63 15.6 24.1
US
Amgen Inc
NASDAQ:AMGN
150.5B USD 4.6 35.6 16.8 31.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD 11.3 -250.9 25 26.3
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 4 903.4 10 10
US
Epizyme Inc
F:EPE
94.1B EUR 1 863.9 -475.6 -517.9 -504.1
AU
CSL Ltd
ASX:CSL
135.7B AUD 5.9 33.2 20.5 25.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.9B USD 6 17.8 16.3 18.1
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.1 -59.2 -53.4
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.9 -132.9 -105.2 -76.6
P/E Multiple
Earnings Growth
NO
Arcticzymes Technologies ASA
OSE:AZT
Average P/E: 191.9
98.5
156%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 646.3 N/A
US
Abbvie Inc
NYSE:ABBV
63
412%
US
Amgen Inc
NASDAQ:AMGN
35.6
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -250.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
903.4
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.6 N/A
AU
CSL Ltd
ASX:CSL
33.2
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -132.9 N/A
EV/EBITDA Multiple
EBITDA Growth
NO
Arcticzymes Technologies ASA
OSE:AZT
Average EV/EBITDA: 31.5
116.7
14%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 147.8 N/A
US
Abbvie Inc
NYSE:ABBV
15.6
29%
US
Amgen Inc
NASDAQ:AMGN
16.8
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25
43%
US
Gilead Sciences Inc
NASDAQ:GILD
10
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -517.9 N/A
AU
CSL Ltd
ASX:CSL
20.5
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.3
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.2 N/A
EV/EBIT Multiple
EBIT Growth
NO
Arcticzymes Technologies ASA
OSE:AZT
Average EV/EBIT: 22.6
Negative Multiple: -352.6
314%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 658.5 N/A
US
Abbvie Inc
NYSE:ABBV
24.1
88%
US
Amgen Inc
NASDAQ:AMGN
31.8
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -504.1 N/A
AU
CSL Ltd
ASX:CSL
25.5
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top